JP2022519636A5 - - Google Patents

Info

Publication number
JP2022519636A5
JP2022519636A5 JP2021545714A JP2021545714A JP2022519636A5 JP 2022519636 A5 JP2022519636 A5 JP 2022519636A5 JP 2021545714 A JP2021545714 A JP 2021545714A JP 2021545714 A JP2021545714 A JP 2021545714A JP 2022519636 A5 JP2022519636 A5 JP 2022519636A5
Authority
JP
Japan
Application number
JP2021545714A
Other languages
Japanese (ja)
Other versions
JP7682096B2 (ja
JP2022519636A (ja
JPWO2020163248A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/016460 external-priority patent/WO2020163248A1/en
Publication of JP2022519636A publication Critical patent/JP2022519636A/ja
Publication of JP2022519636A5 publication Critical patent/JP2022519636A5/ja
Publication of JPWO2020163248A5 publication Critical patent/JPWO2020163248A5/ja
Application granted granted Critical
Publication of JP7682096B2 publication Critical patent/JP7682096B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021545714A 2019-02-04 2020-02-03 スプライシングを調節するための方法および組成物 Active JP7682096B2 (ja)

Applications Claiming Priority (19)

Application Number Priority Date Filing Date Title
US201962800779P 2019-02-04 2019-02-04
US201962800691P 2019-02-04 2019-02-04
US201962800720P 2019-02-04 2019-02-04
US62/800,720 2019-02-04
US62/800,691 2019-02-04
US62/800,779 2019-02-04
US201962801206P 2019-02-05 2019-02-05
US201962801236P 2019-02-05 2019-02-05
US201962801208P 2019-02-05 2019-02-05
US201962801212P 2019-02-05 2019-02-05
US201962801231P 2019-02-05 2019-02-05
US201962801387P 2019-02-05 2019-02-05
US62/801,208 2019-02-05
US62/801,231 2019-02-05
US62/801,387 2019-02-05
US62/801,206 2019-02-05
US62/801,236 2019-02-05
US62/801,212 2019-02-05
PCT/US2020/016460 WO2020163248A1 (en) 2019-02-04 2020-02-03 Methods and compositions for modulating splicing

Publications (4)

Publication Number Publication Date
JP2022519636A JP2022519636A (ja) 2022-03-24
JP2022519636A5 true JP2022519636A5 (https=) 2023-02-09
JPWO2020163248A5 JPWO2020163248A5 (https=) 2023-02-09
JP7682096B2 JP7682096B2 (ja) 2025-05-23

Family

ID=71948378

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021545714A Active JP7682096B2 (ja) 2019-02-04 2020-02-03 スプライシングを調節するための方法および組成物

Country Status (5)

Country Link
EP (1) EP3920917A4 (https=)
JP (1) JP7682096B2 (https=)
KR (1) KR102925387B1 (https=)
CN (2) CN114007614A (https=)
WO (1) WO2020163248A1 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI721623B (zh) 2018-10-31 2021-03-11 美商基利科學股份有限公司 經取代之6-氮雜苯并咪唑化合物
TW202136261A (zh) 2018-10-31 2021-10-01 美商基利科學股份有限公司 經取代之6-氮雜苯并咪唑化合物
WO2020163405A1 (en) 2019-02-05 2020-08-13 Skyhawk Therapeutics, Inc. Methods and compositions for modulating splicing
JP7551629B2 (ja) 2019-02-05 2024-09-17 スカイホーク・セラピューティクス・インコーポレーテッド スプライシングを調節するための方法および組成物
WO2020163401A1 (en) * 2019-02-05 2020-08-13 Skyhawk Therapeutics, Inc. Methods and compositions for modulating splicing
JP7603594B2 (ja) * 2019-02-06 2024-12-20 スカイホーク・セラピューティクス・インコーポレーテッド スプライシングを調節するための方法および組成物
JP7603595B2 (ja) * 2019-02-06 2024-12-20 スカイホーク・セラピューティクス・インコーポレーテッド スプライシングを調節するための方法および組成物
US11453681B2 (en) 2019-05-23 2022-09-27 Gilead Sciences, Inc. Substituted eneoxindoles and uses thereof
TW202131920A (zh) 2019-11-01 2021-09-01 瑞士商諾華公司 剪接調節子用於減慢杭丁頓氏舞蹈症進展的治療之用途
US11618751B1 (en) 2022-03-25 2023-04-04 Ventus Therapeutics U.S., Inc. Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 derivatives
CA3182912A1 (en) 2020-05-13 2021-11-18 Chdi Foundation, Inc. Htt modulators for treating huntington's disease
MX2023001558A (es) * 2020-08-05 2023-04-26 Skyhawk Therapeutics Inc Composiciones para modular el corte y empalme.
IL301964A (en) 2020-10-08 2023-06-01 Redona Therapeutics Inc History of benzo[H]quinazoline-4-amine and thiano[2,3-H]quinazoline-4-amine for cancer treatment
US11319319B1 (en) 2021-04-07 2022-05-03 Ventus Therapeutics U.S., Inc. Compounds for inhibiting NLRP3 and uses thereof
US20240239758A1 (en) 2021-04-28 2024-07-18 Astellas Pharma Inc. Substituted triazine compound
KR20240019083A (ko) * 2021-06-04 2024-02-14 에프. 호프만-라 로슈 아게 트리아진 유도체 및 암 치료에서 이의 용도
MX2024005933A (es) 2021-11-17 2024-08-06 Chdi Foundation Inc Moduladores de htt pata tratar la enfermedad de huntington.
US20260015353A1 (en) * 2022-07-21 2026-01-15 Hoffmann-La Roche Inc. Novel compounds
US12331048B2 (en) 2022-10-31 2025-06-17 Ventus Therapeutics U.S., Inc. Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 inhibitors
WO2026067767A1 (zh) * 2024-09-30 2026-04-02 普罗思特(南京)生物科技有限公司 取代的哒嗪衍生物及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ227684A (en) * 1988-01-30 1991-07-26 Merck Sharp & Dohme Pyrazine, pyridazine, and pyrimidine derivatives and pharmaceutical compositions
GB9005737D0 (en) * 1990-03-14 1990-05-09 Beecham Group Plc Novel compounds
UA92083C2 (ru) * 2006-05-19 2010-09-27 Эбботт Леборетриз Азабициклические алкановые производные, замещенные конденсированным бициклогетероциклом
JP2020523365A (ja) * 2017-06-14 2020-08-06 ピーティーシー セラピューティクス,インコーポレーテッド Rnaスプライシングを改変する方法
EA202092001A1 (ru) * 2018-03-27 2021-01-29 ПиТиСи ТЕРАПЬЮТИКС, ИНК. Соединения для лечения болезни гентингтона

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
BR112023012656A2 (https=)
BR112021014123A2 (https=)
BR112023009656A2 (https=)
BR112022009896A2 (https=)
BR112021017747A2 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021018859A2 (https=)
BR102021015500A2 (https=)
BR102021007058A2 (https=)
BR102020022030A2 (https=)
BR112023016292A2 (https=)
BR112023011539A2 (https=)
BR112023011610A2 (https=)
BR112023008976A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR102021018167A2 (https=)
BR102021017576A2 (https=)
BR102021016837A2 (https=)
BR102021016551A2 (https=)